Safety Data Exchange Agreements (SDEAs) Checklist
PV partnership contract checklist.
2 400 SEK
Need Help? Ask Us or Request Inquire
- Use of Documents and Responsibility
All documents, templates, dossiers, and regulatory materials provided by VYOCURE are offered on an “as is” basis.
VYOCURE does not take responsibility for the accuracy, completeness, or regulatory compliance of any materials.
It is the customer’s sole responsibility to review, adapt, and verify all documents to ensure they meet applicable laws, regulations, and specific requirements for their intended use or market. - Delivery Time
Delivery of digital products and materials is typically completed within 2-5 business days after payment confirmation.
Delays may occur in exceptional cases, and customers will be notified accordingly. - Use & Non-Disclosure Notice
By purchasing this digital document, you are permitted to use it solely for your own internal personal or business purposes. You may not copy, reproduce, modify, share, distribute, resell, publish, or otherwise make this document or its contents available to any third party in any form. Any unauthorized use is strictly prohibited and may result in legal action, including claims for damages. - Acceptance
By proceeding with checkout, you confirm that you have read, understood, and accepted the terms and conditions.
Purpose:
Provides a structured checklist to support the preparation, review, and maintenance of Safety Data Exchange Agreements to ensure clear definition of pharmacovigilance data exchange responsibilities between parties.
Regulatory Alignment:
Aligned with EU pharmacovigilance requirements, including EU GVP Module I (Pharmacovigilance Systems and Quality Systems), and relevant interfaces with EU GMP quality systems.
Included Files:
• Safety Data Exchange Agreement checklist
• Data exchange scope and responsibility verification fields
• Agreement review and update tracking sections
Format:
Microsoft Word or Microsoft Excel (fully editable)
Intended Users:
Marketing authorisation holders, pharmacovigilance teams, quality assurance, legal, and regulatory functions responsible for pharmacovigilance agreements and data exchange oversight.